Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis model

被引:23
作者
Keenan, RM [1 ]
Lago, MA [1 ]
Miller, WH [1 ]
Ali, FE [1 ]
Cousins, RD [1 ]
Hall, LB [1 ]
Hwang, SM [1 ]
Jakas, DR [1 ]
Kwon, C [1 ]
Louden, C [1 ]
Nguyen, TT [1 ]
Ohlstein, EH [1 ]
Rieman, DJ [1 ]
Ross, ST [1 ]
Samanen, JM [1 ]
Smith, BR [1 ]
Stadel, J [1 ]
Takata, DT [1 ]
Vickery, L [1 ]
Yuan, CCK [1 ]
Yue, TL [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Div Res & Dev, Collegeville, PA 19426 USA
关键词
D O I
10.1016/S0960-894X(98)00556-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the 3-oxo-1,4-benzodiazepine-2-acetic acid series of vitronectin receptor (alpha v beta 3) antagonists, a compound containing an imidazopyridine arginine mimetic was discovered which had sufficient potency and iv pharmacokinetics for demonstration of efficacy in a rat restenosis model. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3171 / 3176
页数:6
相关论文
共 14 条
[1]   INHIBITION OF NEOINTIMAL HYPERPLASIA BY BLOCKING ALPHA(V)BETA(3), INTEGRIN WITH A SMALL PEPTIDE ANTAGONIST GPENGRGDSPCA [J].
CHOI, ET ;
ENGEL, L ;
CALLOW, AD ;
SUN, SP ;
TRACHTENBERG, J ;
SANTORO, S ;
RYAN, US .
JOURNAL OF VASCULAR SURGERY, 1994, 19 (01) :125-134
[2]   Discovery of potent nonpeptide vitronectin receptor (alpha(v)beta(3)) antagonists [J].
Keenan, RM ;
Miller, WH ;
Kwon, C ;
Ali, FE ;
Callahan, JF ;
Calvo, RR ;
Hwang, SM ;
Kopple, KD ;
Peishoff, CE ;
Samanen, JM ;
Wong, AS ;
Yuan, CK ;
Huffman, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (15) :2289-2292
[3]  
KEENAN RM, 1998, BIOORG MED CHEM LETT, V8
[4]   Cloning and characterization of a novel integrin beta(3) subunit [J].
Kumar, CS ;
James, IE ;
Wong, A ;
Mwangi, V ;
Feild, JA ;
Nuthulaganti, P ;
Connor, JR ;
Eichman, C ;
Ali, F ;
Hwang, SM ;
Rieman, DJ ;
Drake, FH ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16390-16397
[5]  
Lefkovits J, 1996, EUR HEART J, V17, P9
[6]   OSTEOPONTIN PROMOTES VASCULAR CELL-ADHESION AND SPREADING AND IS CHEMOTACTIC FOR SMOOTH-MUSCLE CELLS IN-VITRO [J].
LIAW, L ;
ALMEIDA, M ;
HART, CE ;
SCHWARTZ, SM ;
GIACHELLI, CM .
CIRCULATION RESEARCH, 1994, 74 (02) :214-224
[7]   INHIBITION OF INTEGRIN FUNCTION BY A CYCLIC RGD-CONTAINING PEPTIDE PREVENTS NEOINTIMA FORMATION [J].
MATSUNO, H ;
STASSEN, JM ;
VERMYLEN, J ;
DECKMYN, H .
CIRCULATION, 1994, 90 (05) :2203-2206
[8]   UPDATE ON THE BIOLOGY AND CLINICAL-STUDY OF RESTENOSIS [J].
OBRIEN, ER ;
SCHWARTZ, SM .
TRENDS IN CARDIOVASCULAR MEDICINE, 1994, 4 (04) :169-178
[9]   CARVEDILOL, A CARDIOVASCULAR DRUG, PREVENTS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION, MIGRATION, AND NEOINTIMAL FORMATION FOLLOWING VASCULAR INJURY [J].
OHLSTEIN, EH ;
DOUGLAS, SA ;
SUNG, CP ;
YUE, TL ;
LOUDEN, C ;
ARLETH, A ;
POSTE, G ;
RUFFOLO, RR ;
FEUERSTEIN, GZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6189-6193
[10]   RANDOMIZED TRIAL OF CORONARY INTERVENTION WITH ANTIBODY AGAINST PLATELET IIB/IIIA INTEGRIN FOR REDUCTION OF CLINICAL RESTENOSIS - RESULTS AT 6 MONTHS [J].
TOPOL, EJ ;
CALIFF, RM ;
WEISMAN, HF ;
ELLIS, SG ;
TCHENG, JE ;
WORLEY, S ;
IVANHOE, R ;
GEORGE, BS ;
FINTEL, D ;
WESTON, M ;
SIGMON, K ;
ANDERSON, KM ;
LEE, KL ;
WILLERSON, JT ;
SMITH, CR ;
WEISMAN, H .
LANCET, 1994, 343 (8902) :881-886